SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
---|---|---|---|---|---|---|---|---|---|
10-Oct-24 5:15 PM View: | Aggarwal Gaurav Director | Unicycive Therapeutics, Inc. (UNCY) | 09-Oct-24 | Conversion | 5,500,000 | -- | -- | 123% 4.47M to 9.97M | |
13-Jul-23 6:10 PM View: | Gupta Shalabh K. CEO Director | Unicycive Therapeutics, Inc. (UNCY) | 11-Jul-23 | Option Exercise | 104,612 | -- | -- | 4% 2.42M to 2.53M | |
13-Jul-23 7:01 PM View: | Gupta Pramod EVP, Pharmaceuticals and BD | Unicycive Therapeutics, Inc. (UNCY) | 11-Jul-23 | Option Exercise | 41,845 | -- | -- | 100% 0 to 41.84K | |
13-Jul-23 7:33 PM View: | Jermasek Douglas EVP of Corporate Strategy | Unicycive Therapeutics, Inc. (UNCY) | 11-Jul-23 | Option Exercise | 104,612 | -- | -- | 149% 70.4K to 175.01K | |
13-Jul-23 8:42 PM View: | Aggarwal Gaurav Director | Unicycive Therapeutics, Inc. (UNCY) | 11-Jul-23 | Conversion | 3,470,150 | -- | -- | 100% 0 to 3.47M | |
30-Aug-22 5:01 PM View: | Schiller Brigitte Director | Unicycive Therapeutics, Inc. (UNCY) | 15-Jul-22 | Option Exercise | 26,738 | -- | -- | 100% 0 to 26.74K | |
17-May-22 11:04 AM View: | Schiller Brigitte Director | Unicycive Therapeutics, Inc. (UNCY) | 16-May-22 | Private Purchase | 15,000 | $0.82 | $12,375.00 | 100% 0 to 15.0K |